Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00047528 · ClinicalTrials.gov registry record · Phase 3
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00047528 is a Phase 3 study that has completed, run by Alcon Research.
The verdict
NCT00047528, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
Interventions
- DRUG Alcon Investigational Agent
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2003-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00047528
The ClinicalTrials.gov registry entry for NCT00047528 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alcon Investigational Agent is the first listed.
NCT00047528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00047528 about?
NCT00047528 is a clinical study titled "Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41". To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.
What is the current status of trial NCT00047528?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-01. Estimated completion is 2003-11.
What interventions are being tested in trial NCT00047528?
The interventions under investigation include: Alcon Investigational Agent (DRUG).
Who is sponsoring clinical trial NCT00047528?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.